Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Tom Boone"'
Autor:
Jonathan D. Oliner, Robert Radinsky, Richard Kendall, Tom Boone, Luke Li, Donald M. McDonald, Beverly L. Falcón, Isaac J. Hayward, Anthony Ndifor, Shao Xiong Wang, Linh Nguyen, Eunju Hurh, Russell Cattley, Grant Shimamoto, Eric Hsu, Mark L. Michaels, Seog Joon Han, Haejin Kim, David Cordover, Paul Hughes, Sean Caenepeel, Karen Rex, Ling Wang, James McCabe, Brad Bolon, Juan Estrada, Ji-Rong Sun, Tani Ann Lee, Dongyin Yu, Juan Leal, Stephen Kaufman, Hosung Min, James Bready, Angela Coxon
Supplementary Figure 3 from Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2934ed8c6f207f77eea17ceb99211e41
https://doi.org/10.1158/1535-7163.22486041.v1
https://doi.org/10.1158/1535-7163.22486041.v1
Autor:
Jonathan D. Oliner, Robert Radinsky, Richard Kendall, Tom Boone, Luke Li, Donald M. McDonald, Beverly L. Falcón, Isaac J. Hayward, Anthony Ndifor, Shao Xiong Wang, Linh Nguyen, Eunju Hurh, Russell Cattley, Grant Shimamoto, Eric Hsu, Mark L. Michaels, Seog Joon Han, Haejin Kim, David Cordover, Paul Hughes, Sean Caenepeel, Karen Rex, Ling Wang, James McCabe, Brad Bolon, Juan Estrada, Ji-Rong Sun, Tani Ann Lee, Dongyin Yu, Juan Leal, Stephen Kaufman, Hosung Min, James Bready, Angela Coxon
AMG 386 is an investigational first-in-class peptide-Fc fusion protein (peptibody) that inhibits angiogenesis by preventing the interaction of angiopoietin-1 (Ang1) and Ang2 with their receptor, Tie2. Although the therapeutic value of blocking Ang2 h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28fc85f3746b4b3881e43684fd11d58a
https://doi.org/10.1158/1535-7163.c.6532206.v1
https://doi.org/10.1158/1535-7163.c.6532206.v1
Autor:
Jonathan D. Oliner, Robert Radinsky, Richard Kendall, Tom Boone, Luke Li, Donald M. McDonald, Beverly L. Falcón, Isaac J. Hayward, Anthony Ndifor, Shao Xiong Wang, Linh Nguyen, Eunju Hurh, Russell Cattley, Grant Shimamoto, Eric Hsu, Mark L. Michaels, Seog Joon Han, Haejin Kim, David Cordover, Paul Hughes, Sean Caenepeel, Karen Rex, Ling Wang, James McCabe, Brad Bolon, Juan Estrada, Ji-Rong Sun, Tani Ann Lee, Dongyin Yu, Juan Leal, Stephen Kaufman, Hosung Min, James Bready, Angela Coxon
Supplementary Methods, Figure Legends, and References from Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54f1f07abbb748f03b8d216b421c4503
https://doi.org/10.1158/1535-7163.22486035
https://doi.org/10.1158/1535-7163.22486035
Autor:
Jonathan D. Oliner, Robert Radinsky, Richard Kendall, Tom Boone, Luke Li, Donald M. McDonald, Beverly L. Falcón, Isaac J. Hayward, Anthony Ndifor, Shao Xiong Wang, Linh Nguyen, Eunju Hurh, Russell Cattley, Grant Shimamoto, Eric Hsu, Mark L. Michaels, Seog Joon Han, Haejin Kim, David Cordover, Paul Hughes, Sean Caenepeel, Karen Rex, Ling Wang, James McCabe, Brad Bolon, Juan Estrada, Ji-Rong Sun, Tani Ann Lee, Dongyin Yu, Juan Leal, Stephen Kaufman, Hosung Min, James Bready, Angela Coxon
Supplementary Figure 1 from Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::423e5ef205e090bf0f7e3fd936b186f7
https://doi.org/10.1158/1535-7163.22486047
https://doi.org/10.1158/1535-7163.22486047
Autor:
Jonathan D. Oliner, Robert Radinsky, Richard Kendall, Tom Boone, Luke Li, Donald M. McDonald, Beverly L. Falcón, Isaac J. Hayward, Anthony Ndifor, Shao Xiong Wang, Linh Nguyen, Eunju Hurh, Russell Cattley, Grant Shimamoto, Eric Hsu, Mark L. Michaels, Seog Joon Han, Haejin Kim, David Cordover, Paul Hughes, Sean Caenepeel, Karen Rex, Ling Wang, James McCabe, Brad Bolon, Juan Estrada, Ji-Rong Sun, Tani Ann Lee, Dongyin Yu, Juan Leal, Stephen Kaufman, Hosung Min, James Bready, Angela Coxon
Supplementary Figure 2 from Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::101a3ffc436ea2111d452cdf846600a7
https://doi.org/10.1158/1535-7163.22486044.v1
https://doi.org/10.1158/1535-7163.22486044.v1
Autor:
Jonathan D. Oliner, Robert Radinsky, Richard Kendall, Tom Boone, Luke Li, Donald M. McDonald, Beverly L. Falcón, Isaac J. Hayward, Anthony Ndifor, Shao Xiong Wang, Linh Nguyen, Eunju Hurh, Russell Cattley, Grant Shimamoto, Eric Hsu, Mark L. Michaels, Seog Joon Han, Haejin Kim, David Cordover, Paul Hughes, Sean Caenepeel, Karen Rex, Ling Wang, James McCabe, Brad Bolon, Juan Estrada, Ji-Rong Sun, Tani Ann Lee, Dongyin Yu, Juan Leal, Stephen Kaufman, Hosung Min, James Bready, Angela Coxon
Supplementary Figure 4 from Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f0a5f009cdf18244a8365e54904ef38
https://doi.org/10.1158/1535-7163.22486038
https://doi.org/10.1158/1535-7163.22486038
Autor:
Brian Mingtung Chan, Kelly A Berry, David W. Brankow, Chadwick T. King, Sylvia Nai-Yu Hu, Nebojsa Kezunovic, Tom Boone, Licheng Shi, Cen Xu, Colin V. Gegg, Matt R. Kelley, Hsieng Sen Lu
Publikováno v:
ACS Pharmacol Transl Sci
[Image: see text] In 2018, the United States Food and Drug Administration (FDA) approved Aimovig (erenumab) for the prevention of migraine. Erenumab is the first FDA approved antibody therapeutic against a G-protein-coupled receptor, the canonical re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0a97f4f56650c1bbf83553db82caa76
https://doi.org/10.1021/acsptsci.9b00061
https://doi.org/10.1021/acsptsci.9b00061
Publikováno v:
ADVANCED THERAPEUTICS. 1:1870024
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b79431e24c77137389cac97d921524b
https://doi.org/10.1002/adtp.201870024
https://doi.org/10.1002/adtp.201870024
Autor:
Sean Caenepeel, Stephen J. Kaufman, Juan Leal, Eric Hsu, Haejin Kim, Ji-Rong Sun, Juan Estrada, Isaac J. Hayward, Paul E. Hughes, Tani Ann Lee, Dongyin Yu, Brad Bolon, Russell C. Cattley, Beverly L. Falcón, Seog Joon Han, David Cordover, James M. McCabe, James Bready, Robert Radinsky, Tom Boone, Ling Wang, Luke Li, Anthony Ndifor, Richard Kendall, Linh T. Nguyen, Shao Xiong Wang, Grant Shimamoto, Eunju Hurh, Hosung Min, Mark Leo Michaels, Jonathan D. Oliner, Karen Rex, Angela Coxon, Donald M. McDonald
Publikováno v:
Molecular Cancer Therapeutics. 9:2641-2651
AMG 386 is an investigational first-in-class peptide-Fc fusion protein (peptibody) that inhibits angiogenesis by preventing the interaction of angiopoietin-1 (Ang1) and Ang2 with their receptor, Tie2. Although the therapeutic value of blocking Ang2 h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75911dd240dfae1bf1e5a0fa5ce1486
https://doi.org/10.1158/1535-7163.mct-10-0213
https://doi.org/10.1158/1535-7163.mct-10-0213
Publikováno v:
ADVANCED THERAPEUTICS. 1:1800082
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39d35891cebf9ad236d56b2718f85d3e
https://doi.org/10.1002/adtp.201800082
https://doi.org/10.1002/adtp.201800082